We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0QXH market cap is 12.16M. The company's latest EPS is EUR and P/E is N/A.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 843k | 6.2M | 485k | 750k | 7k |
| Operating Income | -10.11M | -4.16M | -12.86M | -8.07M | -861k |
| Net Income | -11.69M | -2.43M | -12.02M | -4.46M | -3.35M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 6.8M | 24.66M | 15.85M | 12.85M | 11.85M |
| Total Liabilities | 2.93M | 2.54M | 5.68M | 12.85M | 11.85M |
| Total Equity | 3.86M | 22.12M | 10.17M | 0 | 0 |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.57M | -4.15M | -12.02M | -5.71M | -1.2M |
| Investing | 3k | 961k | -1.7M | 68k | 26k |
| Financing | 2.98M | 21.62M | -359k | -57k | N/A |
| Market Cap | 12.16M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 6.77M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 1.796 |
| 52 Week Low | 1.796 |
| Spread (Intraday) | 0.15 (7.91%) |
| Company Name | Epigenomics Ag |
| Address |
geneststra��e 5 berlin 10829 |
| Website | https://www.epigenomics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
